196 related articles for article (PubMed ID: 17318320)
41. Reactivation of ocular toxoplasmosis in fellow unaffected eye.
Seng Lee M; Boyce RL; Clarke JR
Eur J Ophthalmol; 2004; 14(4):338-40. PubMed ID: 15309981
[TBL] [Abstract][Full Text] [Related]
42. Retinal detachment associated with ocular toxoplasmosis.
Faridi A; Yeh S; Suhler EB; Smith JR; Flaxel CJ
Retina; 2015 Feb; 35(2):358-63. PubMed ID: 25127047
[TBL] [Abstract][Full Text] [Related]
43. Ocular toxoplasmosis: clinical characteristics in pediatric patients.
Garza-Leon M; Garcia LA
Ocul Immunol Inflamm; 2012 Apr; 20(2):130-8. PubMed ID: 22409567
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis.
Moshfeghi DM; Dodds EM; Couto CA; Santos CI; Nicholson DH; Lowder CY; Davis JL
Ophthalmology; 2004 Apr; 111(4):716-25. PubMed ID: 15051204
[TBL] [Abstract][Full Text] [Related]
45. Time patterns of recurrences and factors predisposing for a higher risk of recurrence of ocular toxoplasmosis.
Reich M; Ruppenstein M; Becker MD; Mackensen F
Retina; 2015 Apr; 35(4):809-19. PubMed ID: 25299969
[TBL] [Abstract][Full Text] [Related]
46. Epidemiology of Ocular Toxoplasmosis in Three Community Surveys in the Central Region of Ghana, West Africa.
Abu EK; Boampong JN; Amoabeng JK; Ilechie AA; Kyei S; Owusu-Ansah A; Boadi-Kusi SB; Amoani B; Ayi I
Ophthalmic Epidemiol; 2016; 23(1):14-9. PubMed ID: 26786055
[TBL] [Abstract][Full Text] [Related]
47. Spectral optical coherence tomography findings in patients with ocular toxoplasmosis and active satellite lesions (MINAS Report 1).
Oréfice JL; Costa RA; Scott IU; Calucci D; Oréfice F;
Acta Ophthalmol; 2013 Feb; 91(1):e41-7. PubMed ID: 22970804
[TBL] [Abstract][Full Text] [Related]
48. Toxoplasmosis.
Bonfioli AA; Orefice F
Semin Ophthalmol; 2005; 20(3):129-41. PubMed ID: 16282146
[TBL] [Abstract][Full Text] [Related]
49. Optic nerve involvement in ocular toxoplasmosis: 12 year data from a tertiary referral center in Turkey.
Simsek M; Ozdal PC; Kocer AM
Arq Bras Oftalmol; 2019; 82(4):302-309. PubMed ID: 30970124
[TBL] [Abstract][Full Text] [Related]
50. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
Theaudin M; Bodaghi B; Cassoux N; Romand S; Le Mer Y; Lemaitre C; Fardeau C; Thulliez P; LeHoang P
J Fr Ophtalmol; 2003 Nov; 26(9):921-7. PubMed ID: 14631276
[TBL] [Abstract][Full Text] [Related]
51. A multihousehold study reveals a positive correlation between age, severity of ocular toxoplasmosis, and levels of glycoinositolphospholipid-specific immunoglobulin A.
Portela RW; Bethony J; Costa MI; Gazzinelli A; Vitor RW; Hermeto FM; Correa-Oliveira R; Gazzinelli RT
J Infect Dis; 2004 Jul; 190(1):175-83. PubMed ID: 15195258
[TBL] [Abstract][Full Text] [Related]
52. Ocular toxoplasmosis presenting as neuroretinitis: report of two cases.
Küçükerdönmez C; Akova YA; Yilmaz G
Ocul Immunol Inflamm; 2002 Sep; 10(3):229-34. PubMed ID: 12789599
[TBL] [Abstract][Full Text] [Related]
53. Anti-toxoplasma serotitres in ocular toxoplasmosis.
Phaik CS; Seah S; Guan OS; Chandra MT; Hui SE
Eye (Lond); 1991; 5 ( Pt 5)():636-9. PubMed ID: 1794432
[TBL] [Abstract][Full Text] [Related]
54. Birth prevalence and characteristics of congenital toxoplasmosis in Sergipe, North-east Brazil.
de Melo Inagaki AD; Carvalheiro CG; Cipolotti R; Gurgel RQ; Rocha DA; Pinheiro KS; Araújo RM; Lima DR; Winandy JL; Mussi-Pinhata MM
Trop Med Int Health; 2012 Nov; 17(11):1349-55. PubMed ID: 22974376
[TBL] [Abstract][Full Text] [Related]
55. [Toxoplasmosis-chorioretinitis: clinical course and treatment of seven patients].
Lebech AM; Lebech M; Børme KK; Mathiesen LR
Ugeskr Laeger; 1996 Jul; 158(27):3935-9. PubMed ID: 8701510
[TBL] [Abstract][Full Text] [Related]
56. The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil.
Vallochi AL; Muccioli C; Martins MC; Silveira C; Belfort R; Rizzo LV
Am J Ophthalmol; 2005 Feb; 139(2):350-1. PubMed ID: 15734002
[TBL] [Abstract][Full Text] [Related]
57. [Toxoplasmic retinochoroiditis: relapse vs choroidal neovascular membrane].
Cordero-Coma M; Pérez E; Calleja S; García Ruiz de Morales JM
Arch Soc Esp Oftalmol; 2010 Dec; 85(12):410-3. PubMed ID: 21354510
[TBL] [Abstract][Full Text] [Related]
58. Seroepidemiology of ocular toxoplasmosis-profile of an urban population.
Jain SD; Uppal B; Mehta DK
Indian J Pathol Microbiol; 1998 Oct; 41(4):387-90. PubMed ID: 9866896
[TBL] [Abstract][Full Text] [Related]
59. Chorio-retinal toxoplasmosis: treatment outcomes, lesion evolution and long-term follow-up in a single tertiary center.
Vishnevskia-Dai V; Achiron A; Buhbut O; Berar OV; Musika AA; Elyashiv SM; Hecht I
Int Ophthalmol; 2020 Apr; 40(4):811-821. PubMed ID: 31792847
[TBL] [Abstract][Full Text] [Related]
60. Anti-toxoplasma serotitres in uveitis and ocular toxoplasmosis.
Chee SP; Seah S; Ong SG; Mohan TC; Sng EH
Ann Acad Med Singap; 1992 Mar; 21(2):226-9. PubMed ID: 1519892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
